'Bortezomib' diaporamas de présentation

Rituximab in the Treatment of Follicular Lymphoma

New Evidence reports on presentations given at EHA/ICML 2011. Rituximab in the Treatment of Follicular Lymphoma. Report on EHA/ICML 2011 presentations.

483 views • 35 slides

Multiple Myeloma Update from the XI th International Myeloma Workshop (IMW)

Multiple Myeloma Update from the XI th International Myeloma Workshop (IMW). Welcome and Introduction. Featuring:. Sagar Lonial, MD Winship Cancer Institute Emory University Atlanta, GA. Meletios A.K. Dimopoulos, MD National and Kapodistrian University of Athens Athens, Greece.

707 views • 33 slides

Relapsed and Refractory Myeloma Case 1

459 views • 19 slides

Presented By: Melissa Sukernick Kristin Waterman

636 views • 18 slides

This Is Everything You Need to Know About Bortezomib | AASraw

Bortezomib powder is a cancer chemotherapy drug used to treat certain types of tumors (such as: multiple myeloma, mantle cell lymphoma). It works by slowing or stopping the growth of cancer cells. Visit: http://www.aasraw.com/products/bortezomib-powder/

166 views • 16 slides

1 Jakubowiak AJ et al. Proc ASH 2011 ; Abstract 631.

219 views • 15 slides

Figure 1

A. B. C. D. Figure 1. 40 m M Quercetin. 20 m M Quercetin. 60 m M Quercetin. Control. 60 m M Q 20 nM B. 40 m M Q 20 nM B. Bortezomib. 20 m M Q 20 nM B. A. B. HRC57. DoHH2. U266. RPMI-8226. Figure 2 A and B. C. HRC57. DoHH2. U266. RPMI-8226. Figure 2 C. A. B.

263 views • 11 slides

Role of Bortezomib in Kidney Transplantation

254 views • 11 slides

Steroid-sparing Therapy After Hsp90 Inhibitor Clinical Study

Steroid-sparing Therapy After Hsp90 Inhibitor Clinical Study. Asher A. Chanan-Khan, MD Roswell Park Cancer Institute Buffalo, NY. Patient Has Poor Prognostic Indicators. IgA isotype del(13q) t(4;14). IgA = immunoglobulin A; del(13q) = deletion of the long arm of chromosome 13.

256 views • 9 slides

Supplementary Table 1

Supplementary Table 1. A.

147 views • 9 slides

Supplementary Table 1

Supplementary Table 1. A.

94 views • 9 slides